First Real-World Results Published for New Bispecific Antibody for nAMD
Recorded Courses
hosted byProjects In Knowledge Inc. (PIK)
hosted byProjects In Knowledge Inc. (PIK)
attend it anywhere online
price
Free
First Real-World Results Published for New Bispecific Antibody for nAMD is organized by Projects In Knowledge Inc. (PIK).
Release Date: Apr 26, 2023
Termination Date: Apr 25, 2024
Activity Goal:
The goal of this CME/CE activity is to provide comprehensive and up-to-date information on the best practices in neovascular age-related macular degeneration
Learning Objective(s):
• Summarize the clinical trial data for the treatment strategies and newly approved therapies and their potential for lessening treatment burden in patients with AMD.
Additional details will be posted as soon as information is available.